Balchem has defined a new five-year growth strategy on the heels of its acquisition of Kappa Bioscience and Bergstrom Nutrition, which added K2Vital and OptiMSM to its portfolio. Frederic Boned, senior vice president-general manager at Balchem, reveals how the company is “unlocking new potential” by cross-selling branded ingredients, bringing more awareness to the market and expanding internationally.
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement














